Craig R MacNair

Dr. Craig R MacNair

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2023 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CMCraig R MacNair
Craig R MacNair
SRSteven Rutherford
Steven Rutherford
MTMan-Wah Tan
Man-Wah Tan

1 May 2023 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
LCLindsey A. Carfrae
Lindsey A. Carfrae
KRKenneth Rachwalski
Kenneth Rachwalski
SFShawn French
Shawn French
RGRodion Gordzevich
Rodion Gordzevich
LSLaura Seidel
Laura Seidel
EBEric D. Brown
Eric D. Brown

22 November 2022 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
CMCraig R MacNair
Craig R MacNair
MTMan‐Wah Tan
Man‐Wah Tan

23 March 2022 in ACS Infectious Diseases
Verified
Journal Article
Closed access
CMCraig R MacNair
Craig R MacNair
MFMaya A. Farha
Maya A. Farha
MSMichael H. Serrano-Wu
Michael H. Serrano-Wu
KLKatie K. Lee
Katie K. Lee
BHBrian Hubbard
Brian Hubbard
EBEric D. Brown
Eric D. Brown

2 January 2025 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
MTMegan M. Tu
Megan M. Tu
LCLindsey A. Carfrae
Lindsey A. Carfrae
KRKenneth Rachwalski
Kenneth Rachwalski
SFShawn French
Shawn French
DCDenise Catacutan
Denise Catacutan
EBEric D. Brown
Eric D. Brown

1 August 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
CMCraig R MacNair
Craig R MacNair
CTCaressa N. Tsai
Caressa N. Tsai
SRSteven Rutherford
Steven Rutherford
MTMan-Wah Tan
Man-Wah Tan
Antibiotics found in and inspired by nature are life-saving cures for bacterial infections and have enabled modern medicine. However, the rise in resistance necessitates the discovery and development of novel antibiotics and alternative treatment strategies to prevent the return to a pre-antibiotic era. Once again, nature can serve as a source for new therapies in the form of natural product antibiotics and microbiota-based therapies. Screening of soil bacteria, particularly actinomycetes, identified most of the antibiotics used in the clinic today, but the rediscovery of existing molecules prompted a shift away from natural product discovery. Next-generation sequencing technologies and bioinformatics advances have revealed the untapped metabolic potential harbored within the genomes of environmental microbes. In this review, we first highlight current strategies for mining this untapped chemical space, including approaches to activate silent biosynthetic gene clusters and in situ culturing methods. Next, we describe how using live microbes in microbiota-based therapies can simultaneously leverage many of the diverse antimicrobial mechanisms found in nature to treat disease and the impressive efficacy of fecal microbiome transplantation and bacterial consortia on infection. Nature-provided antibiotics are some of the most important drugs in human history, and new technologies and approaches show that nature will continue to offer valuable inspiration for the next generation of antibacterial therapeutics.